Contact Us

Our solutions

Featured

Prescient Intelligence

Discover our portfolio of AI-powered assessments and intelligent tools designed to support better strategic decisions.

Find out more

News and insights

Featured

Strategy that learns: Rethinking brand planning for a changing environment

Explore why the strongest brand strategies continue beyond annual planning.

Discover The Prescient Pharma Brand Plan Impact Index

Helping senior leaders strengthen strategy and drive better business performance.

The Four Positioning Challenges Every Pharma Launch Team Must Overcome

Discover four positioning challenges that every pharma launch team should address.

About

Careers

Work with us

If you're looking to stretch your thinking, lead with purpose, and be part of a culture that values curiosity, accountability and trust, you're in the right place.

Find out more

Disease and portfolio strategy to maximize long-term value

Navigate disease complexity, map future scenarios and make the portfolio choices that shape investment, development and lifecycle success. 

Connect with our Experts

Specialists in Disease & Portfolio Healthcare Consulting

Our team combines extensive expertise and experience in healthcare consulting. Get to know our Disease & Portfolio strategy-to-impact partners.

Ben Rigby

Associate Partner
View Profile

Deborah Lough

Associate Partner
View Profile

Khushbu Goulden

Associate Partner
View Profile

David Coleiro

Partner
View Profile

Strategic blueprints for high-stakes portfolio decisions

Disease and portfolio strategy require a clear view of where the market is heading, how opportunities could evolve and which choices will create the greatest long-term value. We help teams define the strategic vision, future scenarios and decision frameworks needed to guide development, investment and resource allocation across the lifecycle. 

By connecting disease area insight, portfolio priorities, competitive dynamics and commercial opportunity, we help teams align around where to focus and how to maximize value across brands, indications and assets. Our disease and portfolio strategy capabilities help you make confident decisions across: 

Disease area strategy​

Portfolio strategy​

BD assessment​

Indication sequencing and strategy​

Provide an overarching vision and purpose within a therapeutic landscape to serve as the North Star that guides development and investment decisions.​​​

Co-create the strategy that guides cross-portfolio prioritization, clinical development plan (CDP) decisions and resource allocation to ensure full alignment.​​​​

Apply a systematic, data-driven approach to identifying external commercial opportunities and selecting assets that best fit the existing or future portfolio.​​​​

Clarify strategic choices and timeline mechanics across multiple brands, indications and assets to optimize long-term revenue and protect lifetime asset value.​​​​​

The decisions we help you make

Customer Insights and Understanding

What will shape customer decisions, shift behavior and unlock growth? 

How do we navigate disease complexity, map future scenarios and maximize the value of our entire portfolio? 

How do we build the capabilities, behaviors and tools to make strategy stick? 

Where should we focus, how do we win and what choices create the greatest value? 

How do we create actionable plans that sustain differentiation and drive outcomes? 

What future are we planning for, and where can this asset win? 

How do we launch with confidence, agility and measurable uptake? 

Ready to turn strategy into measurable impact?

The life sciences landscape is full of complexity, but you don't have to navigate it alone. As your strategy-to-impact partner, we are here to help you see further, go deeper and deliver impact where it counts.   

Connect with our Experts